Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 11:8:250-4.
doi: 10.2174/1874325001408010250. eCollection 2014.

Tranexamic Acid Reduces Blood Loss and Transfusion in Patients Undergoing Total Knee Arthroplasty without Tourniquet: A Prospective Randomized Controlled Trial

Fernando Bidolegui  1 , Guillermo Arce  2 , Alfonso Lugones  1 , Sebastián Pereira  1 , Gabriel Vindver  1
Affiliations

Tranexamic Acid Reduces Blood Loss and Transfusion in Patients Undergoing Total Knee Arthroplasty without Tourniquet: A Prospective Randomized Controlled Trial

Fernando Bidolegui et al. Open Orthop J. .

Abstract

Introduction: Blood loss during and after total knee arthroplasty (TKA) can lead to substantial morbidity and the need for blood transfusions. There are several methods to minimize blood loss and to decrease transfusion rates in patients undergoing TKA. Tranexamic acid is an antifibrinolytic agent with known efficacy for achieving these goals. Currently, many surgeons are performing TKA without the use of tourniquet. Consequently, the aim of the study is to evaluate whether tranexamic acid reduces blood loss during and after TKA without the adjunctive use of above-the-knee tourniquet.

Methods: We performed a prospective randomized controlled trial (1:1 fashion) on the use of tranexamic acid versus placebo in 50 patients undergoing TKA (without tourniquet). The treatment group received two (preoperative and postoperative) 15 mg/kg doses. The primary endpoint was blood transfusion rate. We collected data about demographic and procedural characteristics, hemoglobin and hematocrit values, drain blood loss at 24 hours as well as adverse events.

Results: There were no transfusions in the treatment group, whereas 32% of the control group required transfusion (p<0.01). The treatment group had higher hematocrit and hemoglobin levels at 24, 48 and 72 hours after surgery (all p<0.01) and lower drain loss at 24hours (363.4±141 vs 626±260ml, p=<0,001). There were no in-hospital or six-month thromboembolic complications.

Discussion: A double-dose of tranexamic acid was safe and effective, reducing blood loss and preventing the need of blood transfusion in patients undergoing TKA without above-the-need tourniquet.

Keywords: Above-the-knee tourniquet; bleeding; blood transfusion; total knee arthroplasty; tranexamic acid..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Hematocrit (A) and hemoglobin (B) values at baseline, (C) 24, 48 and 72 hours after surgery.
See this image and copyright information in PMC

References

    1. Callaghan JJ, O'Rourke MR, Liu SS. Blood management issues and options. J Arthroplasty. 2005;20: 51–4. - PubMed
    1. Keating EM, Meding JB, Faris PM, Ritter MA. Predictors of transfusion risk in elective knee surgery. Clin Orthop Relat Res. 1998;357: 50–9. - PubMed
    1. Tan J, Chen H, Liu Q, Chen C, Huang W. A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res. 184(2): 880–7. - PubMed
    1. Cushner FD, Friedman RJ. Blood loss in total knee arthroplasty. Clin Orthop Relat Res. 1991;269: 98–101. - PubMed
    1. Goodnough LT, Verbrugge D, Marcus RE. The relationship between hematocrit, blood lost, blood transfused in total knee replacement implications for postoperative blood salvage and reinfusion. Am J Knee Surg. 1995;8(3): 83–7. - PubMed

LinkOut - more resources